MALARIA RESEARCH INSTITUTE
Leading Science for a Malaria-Free World
Founded in May 2001 and continuously supported by Bloomberg Philanthropies, the Johns Hopkins Malaria Research Institute conducts discovery research at the Bloomberg School of Public Health in Baltimore and field research at the Macha Research Trust in Zambia and other sites of endemic malaria in sub-Saharan Africa, India, and elsewhere.
The initial Bloomberg Philanthropies gift established a state-of-the-art research facility with the goal to treat and control malaria, develop a vaccine, and find new drug targets and innovative strategies to prevent and cure the deadly disease. The Institute has contributed to advances in all these areas and is one of the most comprehensive research endeavors focused on malaria globally.
News
Malaria Research Institute director Jane Carlton, PhD spoke with NPR's "Goats and Soda" blog about some good news in a challenging year.
Two new malaria drugs are giving experts hope. David Sullivan, MD comments to the Associated Press.
A tweak to just one gene could render mosquitoes unable to transmit malaria. George Dimopoulos, PhD and colleagues tell NPR all about their research.
New Research
Species composition and blood feeding patterns of understudied Anopheles mosquitoes in southern Zambia, an area of low malaria transmission | Norris Lab
Wolbachia for malaria control | Dimopoulos Lab
Mapping the Genetic Relatedness of Outdoor-Biting Anopheles Mosquitoes in Zambia | Norris Lab
130+
Pilot grants awarded
750+
First- and last-authored publications since 2010